|
|
|
|
LEADER |
01167nam a2200301 u 4500 |
001 |
10009845 |
003 |
upatras |
005 |
20210303084156.0 |
008 |
881025s1991 us eng |
020 |
|
|
|a 0824784847
|
040 |
|
|
|a GR-PaULI
|c GR-PaULI
|
041 |
0 |
|
|a eng
|
082 |
0 |
4 |
|a 615
|
245 |
1 |
0 |
|a Pharmaceutical bioequivalence
|c Edited by Peter G. Welling, Francis L. S. Tse, Shrikant V. Dighe
|
260 |
|
|
|a New York
|b Marcel Dekker, Inc.
|c 1991
|
300 |
|
|
|a ix, 467 p.
|b fig., tab.
|c 24 cm
|
490 |
0 |
|
|a Drugs and the pharmaceutical sciences
|v 48
|
505 |
1 |
|
|a Includes index
|
650 |
|
4 |
|a Φάρμακα
|x Χορήγηση
|9 1266
|
650 |
|
4 |
|a Φαρμακευτική τεχνολογία
|9 36666
|
700 |
1 |
|
|a Dighe, Shrikant V.
|9 125406
|
700 |
1 |
|
|a Tse, Francis L. S.
|9 125398
|
700 |
1 |
|
|a Welling, Peter G.
|9 125399
|
760 |
1 |
|
|a Drugs and the pharmaceutical sciences
|g 48
|
852 |
|
|
|a GR-PaULI
|b ΠΑΤΡΑ
|b ΒΚΠ
|b ΒΣ1
|k ΑΣΧΞ
|h 615 W
|m 25341
|p 025000093688
|t 1
|
942 |
|
|
|2 ddc
|c BK15
|
952 |
|
|
|0 0
|1 0
|4 0
|6 615_000000000000000_W
|7 0
|9 138771
|a LISP
|b LISP
|c BSC
|d 2016-04-24
|i 25341
|l 0
|o 615 W
|p 025000093688
|r 2016-04-24 00:00:00
|t 1
|w 2016-04-24
|y BK15
|
999 |
|
|
|c 90767
|d 90767
|